上海金畔生物科技有限公司代理日本同仁化学 DOJINDO代理商全线产品,欢迎访问官网了解更多信息
上海金畔生物代理Hampton research品牌蛋白结晶试剂耗材工具等,我们将竭诚为您服务,欢迎访问Hampton research官网或者咨询我们获取更多相关Hampton research品牌产品信息。
Products > Optimize Reagents > Optimize – Salts > Ammonium citrate dibasic
Ammonium citrate dibasic
CAT NO
HR2-685
NAME
DESCRIPTION
200 mL
PRICE
$128.00
应用
- Crystallization grade Ammonium citrate dibasic for formulating screens or for optimization
- 结晶级柠檬酸氢铵,用于配制筛选或优化
特征
- Sterile filtered solution
- Formulated in Type 1+ ultrapure water: 18.2 megaohm-cm resistivity at 25°C, < 5 ppb Total Organic Carbon, bacteria free (<1 Bacteria (CFU/ml)), pyrogen free (<0.03 Endotoxin (EU/ml)), RNase-free (< 0.01 ng/mL) and DNase-free (< 4 pg/µL)
- 无菌过滤溶液
在 1+ 型超纯水中配制:25°C 时电阻率为 18.2 兆欧厘米,总有机碳 < 5 ppb,无细菌(<1 细菌 (CFU/ml)),无热原(<0.03 内毒素 (EU/ml)) , 无 RNase (< 0.01 ng/mL) 和无 DNase (< 4 pg/µL)
描述Ammonium citrate dibasic
Synonyms: Citric acid ammonium salt or Diammonium hydrogen citrate or Di-Ammnonium citrate or Ammonium hydrogencitrate
别名:柠檬酸铵盐或柠檬酸氢二铵或柠檬酸二铵或柠檬酸氢铵
C6H14N2O7
(NH4)2C6H6O7
HOC(CO2H)(CH2CO2NH4)2
Mr 226.19
CAS Number 3012-65-5
EC Number 221-146-3
Merck 14,512
Beilstein Registry Number 4925760
RTECS GE7545000
MDL Number MFCD00013068
PubChem Substance ID 24846459
Purity ≥ 99.0%
Measured pH range: 4.7 – 4.8 at 25°C
Measured Conductivity Range: 76.8 – 83.1 mS/cm at 25°C
Measured Refractive Index Range: 1.41993 – 1.42027 at 20°C
Al ≤0.0005%
As ≤0.00001%
Ba ≤0.0005%
Bi ≤0.0005%
Ca ≤0.001%
Cd ≤0.0005%
Cl ≤0.0005%
Co ≤0.0005%
Cr ≤0.0005%
Cu ≤0.0005%
Fe ≤0.0005%
K ≤0.005%
Li ≤0.0005%
Mg ≤0.0005%
Mn ≤0.0005%
Mo ≤0.0005%
Na ≤0.005%
Ni ≤0.0005%
Pb ≤0.0005%
PO4 ≤0.0005%
SO4 ≤0.005%
Sr ≤0.0005%
Zn ≤0.0005%
参考Ammonium citrate dibasic
参考
1. Structure of serum response factor core bound to DNA. Pellegrini, L; Tan, S; Richmond, TJ. Nature 376, 490- 498, 1995.
2. Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-alpha. Bourguet, W; Ruff, M; Chambon, P; Gronemeyer, H; Moras, D. Nature 375, 377- 382, 1995.
1. 与 DNA 结合的血清反应因子核心结构。 佩莱格里尼,L; 谭,S; 里士满,TJ。 自然 376, 490-498, 1995。
2.人核受体RXR-α的配体结合结构域的晶体结构。 布尔格,W; 拉夫,M; 尚邦,P; 格罗内迈尔,H; Moras, D. Nature 375, 377-382, 1995。